Effective August 1, 2024, this database was discontinued. All content will remain searchable and be preserved online for historical purposes only until 2029.
Chronic Myelomonocytic Leukemia
What's New
Last Posted: Oct 05, 2024
- Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study.
Fei Fei, et al. International journal of molecular sciences 2024 0 (18) - PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis.
Ayalew Tefferi, et al. American journal of hematology 2024 0 - Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation.
Amrita Desai, et al. Leukemia research 2024 0 107565 - Utility of KIT Mutations in Myeloid Neoplasms Without Documented Systemic Mastocytosis to Detect Hidden Mast Cells in Bone Marrow.
Do Hwan Kim, et al. Clinical lymphoma, myeloma & leukemia 2024 0 - ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia.
Clifford M Csizmar, et al. Haematologica 2024 0 - Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
Seon Young Kim, et al. Annals of diagnostic pathology 2024 0 152317 - A novel 3q interstitial deletion including GATA2 and ZNF148: A case report.
Elizabeth Martin, et al. American journal of medical genetics. Part A 2024 0 e63621 - NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy.
Laura Hurtado-Navarro, et al. Cell reports. Medicine 2023 0 (12) 101329 - Germline CSF3R Variant in Chronic Myelomonocytic Leukemia: Linking Genetic Predisposition to Uncommon Hemorrhagic Symptoms.
Maria Teresa Bochicchio, et al. International journal of molecular sciences 2023 0 (22) - Impact of BRAF mutation on aggressiveness and outcomes in adult clonal histiocytosis.
Jerome Razanamahery, et al. Frontiers in immunology 2023 0 1260193 - Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.
Alex Bataller, et al. American journal of hematology 2023 0 - Sex-associated differences in genomic profile of chronic myelomonocytic leukemia involving differential representation of SRSF2 gene mutation.
Xavier Calvo, et al. International journal of laboratory hematology 2023 0 - DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features.
Palomo Laura, et al. Epigenetics 2017 0 (1) 8-18 - Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.
Patnaik Mrinal M, et al. American journal of hematology 2017 0 (1) 65-73 - Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis.
Hu Zhihong, et al. Human pathology 2018 0 290-298 - Mutation analysis of therapy-related myeloid neoplasms.
Nishiyama Takahiro, et al. Cancer genetics 2018 0 38-45 - Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients.
Coltro Giacomo, et al. Leukemia 2019 0 (5) 1407-1421 - Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia.
Geissler Klaus, et al. Leukemia research reports 2019 0 100185 - Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia.
Woo Janghee, et al. Haematologica 2019 0 (3) 652-660 - DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease.
Quesada Andrés E, et al. American journal of hematology 2019 0 (7) 757-766 - Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia.
Awada Hassan, et al. Blood advances 2019 0 (3) 339-349 - Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia.
Montalban-Bravo Guillermo, et al. American journal of hematology 2020 0 (2) E50-E53 - Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico.
Jiang Zeju, et al. Oncotarget 2020 0 (47) 4411-4420 - Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype.
Heibl Sonja, et al. Cancers 2020 0 (7) - Juvenile myelomonocytic leukemia - A bona fide RASopathy syndrome.
Lasho Terra, et al. Best practice & research. Clinical haematology 2020 0 (2) 101171 - Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.
Palomo Laura, et al. Blood 2020 0 (16) 1851-1862 - Role of lncRNA Morrbid in PTPN11(Shp2)E76K-driven juvenile myelomonocytic leukemia.
Cai Zhigang, et al. Blood advances 2020 0 (14) 3246-3251 - A novel intensive conditioning regimen for allogeneic hematopoietic stem cell transplantation in the treatment of relapsed/refractory acute myeloid leukemia.
Sun Yanling, et al. Neoplasma 2021 0 (6) 1351-1358 - Looking for somatic mutations in UBA1 in patients with chronic myelomonocytic leukemia associated with systemic inflammation and autoimmune diseases.
Dupuy Henry, et al. Leukemia & lymphoma 2021 0 (1) 250-252 - Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance.
Han Wenmin, et al. International journal of hematology 2021 0 (1) 21-32 - Mutational profile and relative telomere length in Chronic Myelomonocytic Leukemia subgroups according to the 2016 World Health Organization classification.
Martinez-Verbo Laura, et al. Leukemia research 2021 0 106726 - Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series.
Martin de Frémont Grégoire, et al. Frontiers in immunology 2021 0 715053 - Durable Response to Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring MET Intron 14 Mutation: A Case Report.
Leyrat Brice, et al. OncoTargets and therapy 2021 0 3949-3958 - Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
Jian J, et al. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 0 (9) 1731-1742 - A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation.
Gagelmann Nico, et al. Blood advances 2021 0 (6) 1760-1769 - Significance of cardiovascular comorbidity in patients with chronic myelomonocytic leukemia.
Lackner David, et al. Wiener medizinische Wochenschrift (1946) 2022 0 (1-2) 27-33 - Significance of hypergammaglobulinemia in patients with chronic myelomonocytic leukemia.
Zack Marie-Therese, et al. Wiener medizinische Wochenschrift (1946) 2022 0 (1-2) 21-26 - Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.
Calvo Xavier, et al. Blood advances 2022 0 (13) 3921-3931 - A case of refractory systemic lupus erythematosus with monocytosis exhibiting somatic KRAS mutation.
Law Sze-Ming, et al. Inflammation and regeneration 2022 0 (1) 10 - Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report.
Pelkey Lauren J, et al. Cureus 2022 0 (2) e22422
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
Browse full list of rare diseases
A-Z
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: